Press-release for stocks related to bioscience

Prices are updated after-hours

tags : Bioscience crawled time : 12:30

save search

Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
YTEN | $0.261 2.35% 4.49% 380K

Health Technology

| -27.78% | O: -2.89% H: 2.95% C: -2.12%
cleared food bioscience canada

Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors
Published: 2024-02-01 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 77

Health Technology

| -8.22% | O: -4.37% H: 0.0% C: 0.0%
SNY | News | $47.15 1.84% 1.75% 2M

Health Technology

| -9.53% | O: -5.26% H: 0.0% C: 0.0%
MGTX | $5.02 -1.38% -1.19% 150K

Health Technology

| -17.3% | O: 1.81% H: 0.0% C: -1.13%
bioscience sanofi

Jushi Holdings Inc. Announces Opening of Relocated Dispensary in Mount Pocono, Pennsylvania through its Subsidiary, Franklin Bioscience – NE LLC
Published: 2024-01-10 (Crawled : 12:30) - globenewswire.com
JUSHF | $0.647 1.73% 2.74% 84K

n/a

| 12.07% | O: 0.0% H: 0.0% C: -8.98%
bioscience

Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
Published: 2023-10-18 (Crawled : 12:30) - globenewswire.com
YTEN | $0.261 2.35% 4.49% 380K

Health Technology

| -16.4% | O: 19.94% H: 1.88% C: -3.89%
license bioscience research global commercial technology

Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Published: 2023-10-03 (Crawled : 12:30) - globenewswire.com
YTEN | $0.261 2.35% 4.49% 380K

Health Technology

| -21.87% | O: 1.02% H: 1.13% C: 1.13%
harvest bioscience

ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
Published: 2023-10-03 (Crawled : 12:30) - globenewswire.com
ZIVO 4 | $8.0 -17.81% 61

Manufacturing

| 4.17% | O: 5.47% H: 5.19% C: 5.19%
conference bioscience growth

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Published: 2023-09-21 (Crawled : 12:30) - globenewswire.com
DARE | $0.2953 5.46% 4.5% 52K

Health Technology

| -34.05% | O: 4.81% H: 4.87% C: -4.57%
bioscience contraceptive grant technology funding

Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
ZYXI | $11.14 -2.11% -2.15% 160K

Health Technology

| 86.29% | O: 0.0% H: 9.03% C: 4.52%
bioscience

Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s Stainless Steel Capsules
Published: 2022-03-21 (Crawled : 12:30) - biospace.com/
TWST | $29.45 5.37% 5.22% 730K

Health Technology

| -41.76% | O: -2.61% H: 2.62% C: -4.32%
pos control sars-cov-2 positive bioscience

Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans
Published: 2022-03-15 (Crawled : 12:30) - enochianbio.com
ENOB 4 | $0.7 0.0% 88K

Health Technology

| -89.18% | O: -1.39% H: 5.89% C: 2.82%
partnership car-t potential bioscience hiv a3ar

Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
CHRS | $2.18 5.31% 5.48% 1.1K

Health Technology

| -81.92% | O: 1.41% H: 5.81% C: 2.53%
hoice-01 pos presentation positive results positive bioscience results

Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001
Published: 2022-03-14 (Crawled : 12:30) - globenewswire.com
SLDB | $9.04 3.91% 4.08% 190K

Health Technology

| 1072.81% | O: 38.82% H: 0.0% C: 0.0%
sgt-001 financial results ongoing dmd trial report bioscience results

Evelo Biosciences to Participate in Cowen 42nd Annual Health Care Conference
Published: 2022-03-02 (Crawled : 12:30) - globenewswire.com
EVLO | $0.3165 -87.39% 710K

Health Technology

| -89.86% | O: -2.56% H: 1.97% C: 0.99%
health conference bioscience

Liminal BioSciences Repays its Secured Debt Ending its Creditor Relationship with Structured Alpha LP
Published: 2022-02-16 (Crawled : 12:30) - prnewswire.com
LMNL | $8.5 0.12% 0.12% 0

Health Technology

| 899.88% | O: 0.11% H: 6.93% C: 6.93%
bioscience

Liminal BioSciences Repays its Secured Debt Ending its Creditor Relationship with Structured Alpha LP
Published: 2022-02-16 (Crawled : 12:30) - biospace.com/
LMNL | $8.5 0.12% 0.12% 0

Health Technology

| 899.88% | O: 0.11% H: 6.93% C: 6.93%
bioscience

Castle Biosciences to Release Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on Monday, Feb. 28, 2022
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
CSTL | $19.61 1.55% 1.63% 95K

Health Technology

| -54.88% | O: -0.4% H: 4.29% C: 0.94%
day financial results ces conference bioscience results

Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
Published: 2022-02-02 (Crawled : 12:30) - globenewswire.com
BBI | $2.12 16.04%

Health Technology

| 944.91% | O: 20.05% H: 0.0% C: 0.0%
disease bioscience biotech iot

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors
Published: 2022-02-02 (Crawled : 12:30) - biospace.com/
CSTL | $19.61 1.55% 1.63% 95K

Health Technology

| -55.42% | O: -3.02% H: 0.0% C: 0.0%
ces bioscience

Castle Biosciences Named a Winner of the 2022 Top Workplaces USA Award
Published: 2022-02-02 (Crawled : 12:30) - biospace.com/
CSTL | $19.61 1.55% 1.63% 95K

Health Technology